Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile

Inclusion Criteria

• •Age 18 years
• •\- BMI \< 35
• •-ASA class I- III
• •-Patients scheduled for surgery requiring general anesthesia with the use of NMBA's
• •* Patients with ability to give oral and written informed consent
• •* -Known or suspected neuromuscular disorders impairing neuromuscular function
• •* -Allergies to muscle relaxants, anesthetics or narcotics
• •A (family) history of malignant hyperthermia
• •* -Women who are or may be pregnant or are currently breast feeding
• •* -Contraindications for the use of neostigmine
• •Intestinal obstruction,
• •COPD GOLD 4
• •* -Abnormal heart rhythm (eg. bradycardia: \< 40/min);
• •* -Surgery requiring neuraxial anesthesia / analgesia
• •* -Preoperative cognitive dysfunction or mental disabilities
• •* -Preexistent significant pulmonary disease with preoperative SpO2 \< 90%
• •* -Preoperative ICU treatment / intubation (ICU patient);
• •* -Need for postoperative ICU treatment or ventilation;